1. Home
  2. Live Updates
  3. Boan Biotech to Present the Pre-clinical Data of Its Proprie

Boan Biotech to Present the Pre-clinical Data of Its Proprie

Boan Biotech to Present the Pre-clinical Data of Its Proprietary CD3+ T-cell Engager Platform and CEA/CD3 Bispecific Antibody at World Bispecific Summit

Boan Biotech to Present the Pre-clinical Data of Its Proprietary CD3+ T-cell Engager Platform and CEA/CD3 Bispecific Antibody at World Bispecific Summit

prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , , Luye Pharma Group , Technology Platform , Phage Display Technology Platform , Bispecific Engager Technology Platform , World Bispecific Summit , Boan Biotech , T Cell Engager , Improve Safety , T Cell Based Approaches , Human Antibody Transgenic Mouse , Bispecifict Cell Engager Technology Platform , Bevacizumab Injection ,